Skip to main content

Articles

Page 59 of 60

  1. Adipose tissue secreted proteins are collectively named adipocytokines and include leptin, adiponectin, resistin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and omentin. Several of thes...

    Authors: Sylvia Wurm, Markus Neumeier, Johanna Weigert, Andreas Schäffler and Christa Buechler
    Citation: Cardiovascular Diabetology 2007 6:7
  2. Diabetes is associated with a cardiomyopathy that is independent of coronary artery disease or hypertension. In the present study we used in vivo magnetic resonance imaging (MRI) and echocardiographic techniqu...

    Authors: Xichun Yu, Yasvir A Tesiram, Rheal A Towner, Andrew Abbott, Eugene Patterson, Shijun Huang, Marion W Garrett, Suresh Chandrasekaran, Satoshi Matsuzaki, Luke I Szweda, Brian E Gordon and David C Kem
    Citation: Cardiovascular Diabetology 2007 6:6
  3. Diabetes mellitus is a growing public health problem, for which efficient and timely surveillance is a key policy. Administrative databases offer relevant opportunities for this purpose. We aim to monitor the ...

    Authors: Stefano Brocco, Cristiana Visentin, Ugo Fedeli, Elena Schievano, Angelo Avogaro, Margherita Andretta, Francesco Avossa and Paolo Spolaore
    Citation: Cardiovascular Diabetology 2007 6:5
  4. The rising prevalence of obesity and metabolic syndrome (MetS) has received increased attention since both place individuals at risk for Type II diabetes and cardiovascular disease. Insulin resistance (IR) has...

    Authors: Sarita Dhuper, Hillel W Cohen, Josephine Daniel, Padmasree Gumidyala, Vipin Agarwalla, Rosemarie St Victor and Sunil Dhuper
    Citation: Cardiovascular Diabetology 2007 6:4
  5. The omental adipose tissue is pathogenetically involved in both type 2 diabetes mellitus (T2D) and chronic inflammatory bowel diseases (IBD) such as Ulcerative colitis (UC) and Crohn's Disease (CD). Thus, adip...

    Authors: Andreas Schäffler, Martina Zeitoun, Hella Wobser, Christa Buechler, Charalampos Aslanidis and Hans Herfarth
    Citation: Cardiovascular Diabetology 2007 6:3
  6. Elevated blood glucose values are a prognostic factor in myocardial infarction (MI) patients. The unfavourable relation between hyperglycemia and outcome is known for admission glucose and fasting glucose afte...

    Authors: Iwan CC van der Horst, Maarten WN Nijsten, Mathijs Vogelzang and Felix Zijlstra
    Citation: Cardiovascular Diabetology 2007 6:2
  7. The high glucose levels typically occurring among adults with type 2 diabetes contribute to blood vessel injury and complications such as blindness, kidney failure, heart disease, and stroke. Higher physical a...

    Authors: Kaberi Dasgupta, Cathy Chan, Deborah Da Costa, Louise Pilote, Mirella De Civita, Nancy Ross, Ian Strachan, Ronald Sigal and Lawrence Joseph
    Citation: Cardiovascular Diabetology 2007 6:1
  8. Coronary artery disease (CAD) is a major vascular complication of diabetes mellitus and reveals high mortality. Up to 30% of diabetic patients with myocardial ischemia remain asymptomatic and are associated wi...

    Authors: Li Jin Pu, Lin Lu, Xue Wei Xu, Rui Yan Zhang, Qi Zhang, Jian Sheng Zhang, Jian Hu, Zheng Kun Yang, Feng Hua Ding, Qiu Jin Chen, Sheng Lou, Jie Shen, Dan Hong Fang and Wei Feng Shen
    Citation: Cardiovascular Diabetology 2006 5:27
  9. In spite of a large amount of studies in anesthetized animals, isolated hearts, and in vitro cardiomyocytes, to our knowledge, myocardial function was never studied in conscious diabetic rats. Myocardial perfo...

    Authors: Giulianna R Borges, Mauro de Oliveira, Helio C Salgado and Rubens Fazan Jr
    Citation: Cardiovascular Diabetology 2006 5:26
  10. The metabolic syndrome together with insulin resistance and their consequences are basic factors in pathogenesis of atherosclerosis. Chronic infections with herpes simplex virus type 1 (HSV-1), cytomegalovirus...

    Authors: Iraj Nabipour, Katayon Vahdat, Seyed Mojtaba Jafari, Raha Pazoki and Zahra Sanjdideh
    Citation: Cardiovascular Diabetology 2006 5:25
  11. Target organ damage (mainly cardiac and renal damage) is easy to evaluate in outpatient clinics and offers valuable information about patient's cardiovascular risk. The purpose of this study was to evaluate, u...

    Authors: Luis Cea-Calvo, Pedro Conthe, Pablo Gómez-Fernández, Fernando de Alvaro and Cristina Fernández-Pérez
    Citation: Cardiovascular Diabetology 2006 5:23
  12. Obstructive sleep apnoea (OSA) is a cardio-metabolic disorder. Whether metabolic syndrome (MS), insulin resistance (IR) and albuminuria are independently associated with OSA is unclear, but defining the intera...

    Authors: A Gruber, F Horwood, J Sithole, NJ Ali and I Idris
    Citation: Cardiovascular Diabetology 2006 5:22
  13. Patients with diabetes already fulfill one diagnostic criterion for MS according to the existing classifications. Our aim was to identify one single clinical parameter, which could effectively predict the pres...

    Authors: Maria Kompoti, Anargiros Mariolis, Alevizos Alevizos, Ioannis Kyriazis, Ioannis Protopsaltis, Eleni Dimou, Ioannis Lentzas, Dimitrios Levisianou, Afroditi Gova and Andreas Melidonis
    Citation: Cardiovascular Diabetology 2006 5:21
  14. Lowering of low-density lipoprotein cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) is clearly efficacious in the treatment and prevention of coronary artery disease. Howe...

    Authors: Alexander Tenenbaum, Enrique Z Fisman, Michael Motro and Yehuda Adler
    Citation: Cardiovascular Diabetology 2006 5:20
  15. The aim of this study was to determine if hypertensive type 2 diabetic patients, when compared to patients with essential hypertension have an increased left ventricular mass index (LVMI) and a worse diastolic...

    Authors: João S Felício, Juliana T Pacheco, Sandra R Ferreira, Frida Plavnik, Valdir A Moisés, Oswaldo Kohlmann Jr, Artur B Ribeiro and Maria T Zanella
    Citation: Cardiovascular Diabetology 2006 5:19
  16. Diabetes mellitus is an important risk factor for increased vein graft failure after bypass surgery. However, the cellular and molecular mechanism(s) underlying vessel attrition in this population remain large...

    Authors: Kevin M Rice, Devashish H Desai, Sunil K Kakarla, Anjaiah Katta, Deborah L Preston, Paulette Wehner and Eric R Blough
    Citation: Cardiovascular Diabetology 2006 5:18
  17. Systemic adiponectin is reduced in patients with cardiovascular disease (CVD) and low adiponectin may contribute to the pathogenesis of atherosclerosis. However, circulating adiponectin is elevated in type 1 d...

    Authors: Sabine Abke, Markus Neumeier, Johanna Weigert, Gabriele Wehrwein, Elke Eggenhofer, Andreas Schäffler, Kevin Maier, Charalampos Aslanidis, Jürgen Schölmerich and Christa Buechler
    Citation: Cardiovascular Diabetology 2006 5:17
  18. Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and...

    Authors: Yoshimitsu Yamasaki, Young-Seol Kim and Ryuzo Kawamori
    Citation: Cardiovascular Diabetology 2006 5:16
  19. Coronary artery disease is the leading cause of death in industrialized countries and most patients with diabetes die from complications of atherosclerosis. The objective of this study was to determine the pre...

    Authors: Alireza Esteghamati, Mehrshad Abbasi, Manouchehr Nakhjavani, Abbas Yousefizadeh, Amelita P Basa and Hamid Afshar
    Citation: Cardiovascular Diabetology 2006 5:15
  20. Tumor necrosis factor-α (TNFα) is a mediator of insulin resistance. Plasma levels of soluble TNFα receptors (sTNFR1 and sTNFR2) probably reflect paracrine action of the cytokine. TNFα is also a regulator of li...

    Authors: Marek Straczkowski, Irina Kowalska, Agnieszka Nikolajuk, Agnieszka Adamska, Malgorzata Karolczuk-Zarachowicz, Monika Karczewska-Kupczewska, Agnieszka Kozlowska and Maria Gorska
    Citation: Cardiovascular Diabetology 2006 5:14
  21. Foam cell formation in diabetic patients often occurs in the presence of high insulin and glucose levels. To test whether hyperinsulinemic hyperglycemic conditions affect foam cell differentiation, we examined...

    Authors: Pavel N Shashkin, Nitin Jain, Yury I Miller, Benjamin A Rissing, Yuqing Huo, Susanna R Keller, George E Vandenhoff, Jerry L Nadler and Thomas M McIntyre
    Citation: Cardiovascular Diabetology 2006 5:13
  22. Adiponectin acts as an antidiabetic, antiinflammatory and antiatherogenic adipokine. These effects are assumed to be mediated by the recently discovered adiponectin receptors AdipoR1 and AdipoR2.

    Authors: Uli C Broedl, Michael Lehrke, Elisabeth Fleischer-Brielmaier, Anne B Tietz, Jutta M Nagel, Burkhard Göke, Peter Lohse and Klaus G Parhofer
    Citation: Cardiovascular Diabetology 2006 5:11
  23. South-Asians have lower adiponectin levels compared to Caucasians. It was not clear however, if this intrinsic feature is related to aspects of glucose metabolism. This study aims to determine the relationship...

    Authors: Hanif Wasim, Nasser M Al-Daghri, Raja Chetty, Phillip G McTernan, A H Barnett and Sudhesh Kumar
    Citation: Cardiovascular Diabetology 2006 5:10
  24. Impaired glucose tolerance (IGT) is associated with increased cardiovascular risk. The pathophysiological mechanisms linking post-challenge hyperglycemia to accelerated atherosclerosis, however remain to be el...

    Authors: Isabella Schmoelzer and Thomas C Wascher
    Citation: Cardiovascular Diabetology 2006 5:9
  25. Anemia and diabetes are risk factors for short-term mortality following an acute myocardial infarction(AMI). Anemia is more prevalent in patients with diabetes. We performed a retrospective study to assess the...

    Authors: David H Shu, Thomas PP Ransom, Colleen M O'Connell, Jafna L Cox, Stephanie M Kaiser, Shirl A Gee, Richard C Rowe, Ehud Ur and Syed Ali Imran
    Citation: Cardiovascular Diabetology 2006 5:8
  26. Diabetes is a major risk factor for cardiovascular disease. In particular, type 1 diabetes compromises the cardiac function of individuals at a relatively early age due to the protracted course of abnormal glu...

    Authors: Rajprasad Loganathan, Mehmet Bilgen, Baraa Al-Hafez, Mohammed D Alenezy and Irina V Smirnova
    Citation: Cardiovascular Diabetology 2006 5:7
  27. Atherosclerosis is an inflammatory disease in which a perpetuated activation of NFkappaB via the RAGE (receptor for advanced glycation end products)-MAPK signalling pathway may play an important pathogenetic r...

    Authors: Philipp Ehlermann, Kai Eggers, Angelika Bierhaus, Patrick Most, Dieter Weichenhan, Johannes Greten, Peter P Nawroth, Hugo A Katus and Andrew Remppis
    Citation: Cardiovascular Diabetology 2006 5:6
  28. Monocytes play an important role in innate immunity and atherosclerosis. A disturbed secretion of cytokines in lipopolysaccharide (LPS) activated monocytes from type 1 diabetes (T1D) patients has been describe...

    Authors: Gabriele Wehrwein, Markus Neumeier, Andreas Schäffler, Andrea Kopp, Johanna Weigert, Sabine Abke, Jürgen Schölmerich and Christa Buechler
    Citation: Cardiovascular Diabetology 2006 5:5
  29. The endothelium is a thin monocelular layer that covers all the inner surface of the blood vessels, separating the circulating blood from the tissues. It is not an inactive organ, quite the opposite. It works ...

    Authors: Ricardo J Esper, Roberto A Nordaby, Jorge O Vilariño, Antonio Paragano, José L Cacharrón and Rogelio A Machado
    Citation: Cardiovascular Diabetology 2006 5:4
  30. Inflammation contributes to cardiovascular disease and is exacerbated with increased adiposity, particularly omental adiposity; however, the role of epicardial fat is poorly understood.

    Authors: Adam R Baker, Nancy F da Silva, David W Quinn, Alison L Harte, Domenico Pagano, Robert S Bonser, Sudhesh Kumar and Philip G McTernan
    Citation: Cardiovascular Diabetology 2006 5:1
  31. To determine the prevalence of, and patient characteristics associated with, antiplatelet therapy in a cohort of primary care patients with Type 1 or Type2 diabetes.

    Authors: Shaun R Miller, Benjamin Littenberg and Charles D MacLean
    Citation: Cardiovascular Diabetology 2005 4:18
  32. Individuals with diabetes are twice as likely to develop peripheral arterial disease (PAD), the manifestation of extensive atherosclerosis throughout the lower extremities. One putative determinant of PAD is t...

    Authors: Rebecca L Pollex, Mary Mamakeesick, Bernard Zinman, Stewart B Harris, Anthony JG Hanley and Robert A Hegele
    Citation: Cardiovascular Diabetology 2005 4:17
  33. Accelerated atherosclerosis is one of the major vascular complications of diabetes. Factors including hyperglycemia and hyperinsulinemia may contribute to accelerated vascular disease. Among the several mechan...

    Authors: Wenlan Duan, Latha Paka and Sivaram Pillarisetti
    Citation: Cardiovascular Diabetology 2005 4:16
  34. The aim of the present study was to evaluate, by heart rate variability (HRV) with 24-hours ECG Holter (HRV), the circadian autonomic activity in offspring of type 2 diabetic subjects and the relation with ins...

    Authors: A Fiorentini, A Perciaccante, A Paris, P Serra and L Tubani
    Citation: Cardiovascular Diabetology 2005 4:15
  35. There are three peroxisome proliferator-activated receptors (PPARs) subtypes which are commonly designated PPAR alpha, PPAR gamma and PPAR beta/delta. PPAR alpha activation increases high density lipoprotein (...

    Authors: Alexander Tenenbaum, Michael Motro and Enrique Z Fisman
    Citation: Cardiovascular Diabetology 2005 4:14
  36. The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study is examining the effects of long-term fibrate therapy on coronary heart disease (CHD) event rates in patients with diabetes mellitus. T...

    Authors:
    Citation: Cardiovascular Diabetology 2005 4:13
  37. Uncontrolled hyperglycemia is the main risk factor in the development of diabetic vascular complications. The endothelial cells are the first cells targeted by hyperglycemia. The mechanism of endothelial injur...

    Authors: Juying Han, Anil K Mandal and Linda M Hiebert
    Citation: Cardiovascular Diabetology 2005 4:12
  38. The objective of this study was to determine the rate of blood pressure control according to 4 sets of Canadian guidelines published over a decade in patients with diabetes mellitus attending Diabetes Centres ...

    Authors: Cory Russell, Peggy Dunbar, Sonia Salisbury, Ingrid Sketris and George Kephart
    Citation: Cardiovascular Diabetology 2005 4:11
  39. Resistin is an adipocyte-derived factor implicated in obesity-associated type 2 diabetes (T2DM). This study examines the association between human serum resistin, T2DM and coronary heart disease.

    Authors: N Al-Daghri, R Chetty, PG McTernan, K Al-Rubean, O Al-Attas, AF Jones and S Kumar
    Citation: Cardiovascular Diabetology 2005 4:10
  40. The vascular endothelial basement membrane and extra cellular matrix is a compilation of different macromolecules organized by physical entanglements, opposing ionic charges, chemical covalent bonding, and cro...

    Authors: Melvin R Hayden, James R Sowers and Suresh C Tyagi
    Citation: Cardiovascular Diabetology 2005 4:9
  41. Drugs in the same class are generally thought to be therapeutically equivalent because of similar mechanisms of action (the so-called "class effect"). However, statins differ in multiple characteristics, inclu...

    Authors: Enrique Z Fisman, Yehuda Adler and Alexander Tenenbaum
    Citation: Cardiovascular Diabetology 2005 4:8
  42. The Use of Rosuvastatin versus Atorvastatin iN type 2 diabetes mellitUS (URANUS) study compared rosuvastatin with atorvastatin for the reduction of low-density lipoprotein cholesterol (LDL-C) in patients with ...

    Authors: Christian Berne and Annica Siewert-Delle
    Citation: Cardiovascular Diabetology 2005 4:7
  43. Metabolic syndrome is a cluster of common cardiovascular risk factors that includes hypertension and insulin resistance. Hypertension and diabetes mellitus are frequent comorbidities and, like metabolic syndro...

    Authors: Cristiana Vitale, Giuseppe Mercuro, Carlotta Castiglioni, Alessandra Cornoldi, Arianna Tulli, Massimo Fini, Maurizio Volterrani and Giuseppe MC Rosano
    Citation: Cardiovascular Diabetology 2005 4:6
  44. Cardiovascular complications, characterized by endothelial dysfunction and accelerated atherosclerosis, are the leading cause of morbidity and mortality associated with diabetes. There is growing evidence that...

    Authors: Jeanette Schultz Johansen, Alex K Harris, David J Rychly and Adviye Ergul
    Citation: Cardiovascular Diabetology 2005 4:5
  45. Vascular calcification is associated with metabolic syndrome, diabetes, hypertension, atherosclerosis, chronic kidney disease, and end stage renal disease. Each of the above contributes to an accelerated and p...

    Authors: Melvin R Hayden, Suresh C Tyagi, Lisa Kolb, James R Sowers and Ramesh Khanna
    Citation: Cardiovascular Diabetology 2005 4:4
  46. In the present study we tested the hypothesis that progression of streptozotocin (STZ)-induced diabetes (14-days to 28-days) would produce renal and vascular dysfunction that correlate with altered p38- mitoge...

    Authors: Hongmei Chen, Sachin Brahmbhatt, Akanksha Gupta and Avadhesh C Sharma
    Citation: Cardiovascular Diabetology 2005 4:3

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions